Prostate-specific antigen (PSA)
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | BIO-PSA |
|---|---|
| Type | Biomarker |
| Aliases | Prostate-specific antigenПростатичний специфічний антиген (ПСА) |
| Status | pending_clinical_signoff |
| Diseases | None declared |
| Sources | None declared |
Biomarker Facts
| Biomarker type | serum_marker |
|---|---|
| Measurement | MethodImmunoassay (ECLIA, CLIA) Unitsng/mL Typical range
|
| Related biomarkers | None declared |
Notes
Workhorse serum biomarker for prostate. Disease-state stratification (mHSPC vs mCRPC vs nmCRPC) and CHAARTED/LATITUDE risk classification rely heavily on PSA dynamics + cross-reference with imaging.
Used By
Indications
IND-PROSTATE-MCRPC-1L-ARPI- IND-PROSTATE-MCRPC-1L-ARPIIND-PROSTATE-MCRPC-1L-PARPI- IND-PROSTATE-MCRPC-1L-PARPIIND-PROSTATE-MCRPC-2L-CABAZITAXEL- IND-PROSTATE-MCRPC-2L-CABAZITAXELIND-PROSTATE-MCRPC-2L-DOCETAXEL- IND-PROSTATE-MCRPC-2L-DOCETAXELIND-PROSTATE-MCRPC-2L-LU-PSMA- IND-PROSTATE-MCRPC-2L-LU-PSMAIND-PROSTATE-MCRPC-2L-PARPI- IND-PROSTATE-MCRPC-2L-PARPIIND-PROSTATE-MCRPC-2L-RADIUM223- IND-PROSTATE-MCRPC-2L-RADIUM223IND-PROSTATE-MHSPC-1L-ARPI-DOUBLET- IND-PROSTATE-MHSPC-1L-ARPI-DOUBLETIND-PROSTATE-MHSPC-1L-TRIPLET- IND-PROSTATE-MHSPC-1L-TRIPLET
Questionnaires
QUEST-PROSTATE-1L-STUB- Prostate adenocarcinoma — first line
Tests
TEST-PSA-SERUM- Serum PSA